Barclays’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-10,349
Closed -$18K 7240
2017
Q1
$18K Sell
10,349
-128,151
-93% -$719K ﹤0.01% 5860
2016
Q4
$1.06M Buy
138,500
+136,106
+5,685% +$2.5M ﹤0.01% 2684
2016
Q3
$103K Buy
2,394
+2,388
+39,800% +$108K ﹤0.01% 4500
2016
Q2
$0 Sell
6
-247
-98% -$14.8K ﹤0.01% 6886
2016
Q1
$14K Buy
+253
New +$13.1K ﹤0.01% 5381
2015
Q4
Sell
-32
Closed -$3K 7034
2015
Q3
$3K Sell
32
-86
-73% -$8.88K ﹤0.01% 6276
2015
Q2
$11K Sell
118
-54
-31% -$3.72K ﹤0.01% 6058
2015
Q1
$9K Sell
172
-2,949
-94% -$117K ﹤0.01% 6314
2014
Q4
$116K Buy
+3,121
New +$98.3K ﹤0.01% 5077

Other funds holding ADPT

Barclays's ADPT Position: Q2 2017 in Review

Barclays sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 10,349 shares — an estimated $18K sold.

Barclays first reported a position in ADPT in Q4 2014 and held it in 9 quarters. The position peaked at $1.06M in Q4 2016. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Barclays reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Barclays sold 10,349 Adeptus Health Inc shares in Q2 2017, an estimated $18K.
  • Barclays first reported a position in Adeptus Health Inc in Q4 2014 and held it in 9 quarters.
  • Barclays's Adeptus Health Inc position peaked at $1.06M in Q4 2016.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.